Financials
- Market Capitalization 75.47 M
- Employee 24
- Founded 2011
- CEO N/A
- Website www.neuraxis.com
- Headquarter Delaware, United States
- FIGI BBG01C9N12C3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.49
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4048 | GANX Gain Therapeutics, Inc. - Common Stock | 1.80 USD | -1.10% | +1.69% | +1.12% | +1.69% | 78.56 M USD | ||
| 4060 | RNTX Rein Therapeutics, Inc. - Common Stock | 0.89 USD | +5.95% | +15.58% | +23.61% | -19.11% | 76.78 M USD | ||
| 4082 | CING Cingulate Inc. - Common Stock | 5.10 USD | -2.30% | -4.32% | +3.03% | -17.21% | 74.16 M USD | ||
| 4083 | CALC CalciMedica, Inc. - Common Stock | 2.17 USD | -1.36% | -5.65% | +193.24% | -30.23% | 74.09 M USD |